MannKind Corp. (MNKD)
5.67
+0.01
(+0.18%)
USD |
NASDAQ |
Dec 31, 16:00
5.66
-0.01
(-0.18%)
After-Hours: 20:00
MannKind Research and Development Expense (TTM): 49.90M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Moderna, Inc. | 3.271B |
| Vertex Pharmaceuticals, Inc. | 3.954B |
| Ocugen, Inc. | 35.49M |
| Protagonist Therapeutics, Inc. | 147.84M |
| Ovid Therapeutics, Inc. | 24.66M |